The Internationalization of Corporate R&D

THE INTERNATIONALIZATION OF CORPORATE R&DReferencesAllen, T. (1977) Managing the Flow of Technology: Technology Transfer and the Disseminationof Technological Information within the R&D Organization,Cambridge: MIT Press.Chacar, A. & M. Lieberman. (2003) “Organizing for Technological Innovation in theU.S. Pharmaceutical Industry,” Advances in Strategic Management, Vol. 20, pp.299–322.Chesbrough, H. (2003) Open Innovation – The New Imperative for Creating and Profitingfrom Technology, Boston: Harvard Business School Press.Cummings, J. (2004) “Work Groups, Structural Diversity and Knowledge Sharing in aGlobal Organization,” Management Science, Vol. 50, No. 3, pp. 352–364.DiMasi, J., R. Hansen & H. Grabowski (2003) “The Price of Innovation: New Estimatesof Drug Development Costs,” Journal of Health Economics, Vol. 22, pp.151–185.Furman, J., M. Kyle, I. Cockburn & R. Henderson (2004) Public and Private Spillovers,Location and the Productivity of Pharmaceutical Research, Paper preparedfor the NBER, CRIW and CREST conference on R&D, Education andProductivity in Paris, August 25–27, 2003.Gambardella, A. (1995) Science and Innovation in the U.S. Pharmaceutical Industry,Cambridge, Cambridge University Press.Jaffe, A. (1989) “Real Effects of Academic Research,” American Economic Review,No. 79, pp. 957–70.Kale, D. (2005) Learning to Innovate: The Indian Pharmaceutical Industry Responseto Emerging TRIPs Regime, Article presented at DRUID Academy Winter 2005Ph.D. Conference.Kyle, M. (2004) “Does Locale Affect R&D Productivity? The Case of Pharmaceuticals,”FRBSF Economic Letter, No. 2004–32, November 12.OECD (2004) Science, Technology and Industry Outlook, OECD, Paris.PhRMA (2004) Annual Membership Survey.PhRMA (2005) Newsrelease, February 18:www.phrma.org/mediaroom/press/releases/18.02.2005.1128.cfm.Regeringskansliet (2005) Läkemedel, bioteknik och medicinteknik – en del av InnovativaSverige, Näringsdepartementet, December 2005.166